Results 61 to 70 of about 115,612 (189)

Dopamine and N-Methyl-D- Aspartate Receptor Interactions in the Neostriatum [PDF]

open access: yesDevelopmental Neuroscience, 1998
This review examines dopamine (DA) and glutamate receptor interactions in the neostriatum (NS) primarily from a neurophysiological perspective. Historically, a clear understanding of the function of DA in the NS has been difficult because it was considered a classical neurotransmitter with either excitatory or inhibitory actions and because many of the
Carlos Cepeda, Michael Levine
openaire   +3 more sources

Long-Term Treatment With Morphine Increases the D-Serine Content in the Rat Brain by Regulating the mRNA and Protein Expressions of Serine Racemase and D-Amino Acid Oxidase

open access: yesJournal of Pharmacological Sciences, 2008
Recent studies indicate that an endogenous co-agonist for an N-methyl-D-aspartate (NMDA) receptor–related glycine site, D-serine, is synthesized by serine racemase and is metabolized by D-amino acid oxidase (DAO) and that acute treatment with morphine ...
Masanobu Yoshikawa   +7 more
doaj   +1 more source

Conformational rearrangement of the NMDA receptor amino-terminal domain during activation and allosteric modulation

open access: yesNature Communications, 2021
N-Methyl-D-aspartate receptors (NMDARs) activation involves closure of the GluN1 and GluN2 subunit ligand binding domains, which is regulated allosterically by the amino-terminal domain (ATD).
Vojtech Vyklicky   +3 more
doaj   +1 more source

A via receptor NMDA-óxido nítrico-GMP cíclico como alvo para o desenvolvimento de medicações antipsicóticas não-dopaminérgicas para a esquizofrenia [PDF]

open access: yes, 2011
Schizophrenia is a devastating disorder that occurs in about 1% of the population worldwide. For over 30 years, it has been considered to be the result of dysfunctional brain dopaminergic pathways.
BAKER, Glen B.   +5 more
core   +4 more sources

Selective vulnerabilities of N-methyl-D-aspartate (NMDA) receptors during brain aging

open access: yesFrontiers in Aging Neuroscience, 2010
N-methyl-D-aspartate (NMDA) receptors are present in high density within the cerebral cortex and hippocampus and play an important role in learning and memory.
Brenna L Brim, Siba R Das
doaj   +1 more source

Spermine regulates N-methyl-d-aspartate receptor desensitization

open access: yesNeuron, 1992
The action of the endogenous polyamine spermine on NMDA-induced responses (in the presence of glycine) was evaluated in cultured spinal cord neurons under voltage- and concentration-clamp conditions. Spermine potentiated NMDA-induced responses in a dose-dependent manner.
openaire   +4 more sources

Targeting harmful effects of non-excitatory amino acids as an alternative therapeutic strategy to reduce ischemic damage

open access: yesNeural Regeneration Research
The involvement of the excitatory amino acids glutamate and aspartate in cerebral ischemia and excitotoxicity is well-documented. Nevertheless, the role of non-excitatory amino acids in brain damage following a stroke or brain trauma remains largely ...
Victoria Jiménez Carretero   +4 more
doaj   +1 more source

Potassium channel activators protect the N-methyl-D-aspartate-induced cerebral vascular dilation after combined hypoxia and ischemia in piglets [PDF]

open access: yes, 1998
Background and Purpose-Cerebral arteriolar dilation to N-methyl-D-aspartate (NMDA) is a neuronally mediated multistep process that is sensitive to cerebral hypoxia and ischemia (H/I).
Bari, Ferenc   +2 more
core  

Update in the research of anti-N-methyl-D-aspartate receptor encephalitis

open access: yesChinese Journal of Contemporary Neurology and Neurosurgery, 2014
doi: 10.3969/j.issn.1672-6731.2014.08 ...
Jia-wei WANG
doaj  

ON or OFF?: Modulating the N-Methyl-D-Aspartate Receptor in Major Depression [PDF]

open access: yesFrontiers in Molecular Neuroscience, 2017
Since the discovery that a single dose of ketamine, an N-methyl-D-aspartate receptor (NMDAR) antagonist, had rapid and long-lasting antidepressant effects, there has been increased interest in using NMDAR modulators in the pharmacotherapy of depression.
Chan, S, Matthews, E, Burnet, P
openaire   +3 more sources

Home - About - Disclaimer - Privacy